NCT03933904 – A Phase II, Single-Arm Open-Label Multi-Center Study of Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease
July 8, 2024
The purpose of this study is to understand the impact of sirolimus on idiopathic multicentric Castleman disease.